Gastritis Flashcards

(21 cards)

1
Q

Gastroduodenal Defense: Pre-epithelial

A
  • Mucous
  • Bicarbonate
  • Surface active Phospholipids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gastroduodenal Defense: Epithelial

A
  • Cellular resistance
  • Restitution
  • Growth factors, Prostaglandins
  • Cell Proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gastroduodenal Defense: Subepithelial

A
  • Blood flow
  • Leukocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of gastritis

A

-Epigastric abdominal pain, N/V, Anorexia/early satiety, hematemesis/ melena, anemia weight loss, symptoms of systemic disorder. Nighttime wakening *think PUD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gastritis: Infection

A
  • H pylori
  • CMV/EBV
  • Candida, Anisakis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gastritis: Drugs

A

-NSAIDS
-Steroids
-Chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Gastritis Inflammatory

A

-IBD
-Eosinophilic
-Celiac
-GVHD
-HSP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gastritis Hypersecretory States

A

-Zollinger Ellison
-G cell hyperplasia
-Short gut
-CF
-Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gastritis: Stress

A

-Trauma,
-Burn injury
-Head injury
-NICU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gastritis: Physical Agents

A

-Corrosive
-Bile Acid
-Exercise
-Radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CMV Gastritis

A
  • Increased in immune compromised, can also be in normal immune patients.
    -Menetrier’s: abdominal pain, vomiting, edema (2/2 PLE). EGD: enlarged folds +/- erosions/ulcers.
    Histology: enlarged torturous glands, CMV+ inclusion bodies, PCR
    Management: usually self limited, supportive, +/- antiviral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NSAIDS

A

Topical damage from pill.
Pharmacological effects (COX inhibition reduce prostaglandins).
NSAIDS can cause ulceration or reactive gastropathy: epithelial hyperplasia, mucin depletion, fibromuscular hyperplasia, vascular ectasia.
May occur after one dose or chronic dosing.
Gastroprotection with PPI may prevent lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IBD Gastritis

A

Upper GI tract (macro and micro) involvement is commonly found, rarely in isolation
Focal gastritis more common in Crohn’s disease, +granuloma can distinguish Crohn’s disease from UC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Celiac disease

A

lymphocytic gastritis or chronic superficial gastritis may be present in up to 1/3 of children with celiac disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute GVHD

A

Nausea, vomiting, anorexia +/- skin, lower GI, and liver findings.
21-100 days after BMT.
Apoptotic cells are hallmark.
Need to rule out CMV infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Zollinger Ellison syndrome symptoms

A
  • Abdominal pain, +/- diarrhea (due to hypergastrinemia).
  • Prolonged PUD despite treatment.
  • Recurrent PUD, complicated PUD,
  • MEN1
17
Q

Zollinger Ellison Syndrome Lab findings

A
  • Elevated fasting gastrin, positive secretin test (provocative test), low gastric pH.
    Endoscopic findings: multiple ulcers in different locations.
18
Q

Zollinger Ellison Syndrome Management

A
  • Identify tumor: gastrinoma triangle.
  • PPI, surgical removal of tumor.
19
Q

Stress related mucosal disease

A

Critically ill patients under physiological stress.
RF: ventilation, major surgery, head injury, multi-organ failure, hemodynamic instability, anti-coagulation.
Data on prevention with acid suppression limited in pediatrics: may decrease UGIB but no change in mortality

20
Q

Corrosive Gastritis

A

Alkali: Liquefactive necrosis. Transmural, esophageal>gastric injury.
Acidic: Coagulative necrosis: more severe gastric injury.
EGD: grade of injury/stricture risk, early therapy.